ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 852 filers reported holding ISHARES TR in Q2 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $282,933 | -23.5% | 2,314 | -20.6% | 0.07% | -23.6% |
| Q2 2023 | $369,810 | +11.7% | 2,913 | +12.0% | 0.09% | +2.3% |
| Q1 2023 | $331,032 | -16.0% | 2,602 | -13.4% | 0.09% | -16.3% |
| Q4 2022 | $394,223 | +4.3% | 3,003 | -7.1% | 0.10% | -7.1% |
| Q3 2022 | $378,000 | -8.5% | 3,234 | -2.8% | 0.11% | +6.7% |
| Q2 2022 | $413,000 | -31.1% | 3,327 | -27.7% | 0.10% | -26.6% |
| Q1 2022 | $599,000 | -2.4% | 4,600 | +14.3% | 0.14% | -18.3% |
| Q4 2021 | $614,000 | +27.1% | 4,025 | +34.7% | 0.18% | +10.8% |
| Q3 2021 | $483,000 | +11.3% | 2,988 | +12.7% | 0.16% | +9.0% |
| Q2 2021 | $434,000 | +5.9% | 2,652 | -2.6% | 0.14% | -7.6% |
| Q1 2021 | $410,000 | +17.5% | 2,723 | +18.1% | 0.16% | -15.6% |
| Q4 2020 | $349,000 | +33.2% | 2,305 | +19.3% | 0.19% | +14.1% |
| Q3 2020 | $262,000 | +8.7% | 1,932 | +9.6% | 0.16% | -6.3% |
| Q2 2020 | $241,000 | +79.9% | 1,763 | +44.7% | 0.17% | +83.2% |
| Q2 2018 | $134,000 | – | 1,218 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |